Back to Authors

Yang, Min

https://orcid.org/0000-0002-4864-6658

A5102942055 | I79463011

Mayo Clinic

Analysis Group (United States)

Citations 1

Cost-effectiveness analysis of regorafenib dose optimization for refractory metastatic colorectal cancer

Journal of Medical Economics | April 23, 2025 | Volume: 28 | Issue: 1 | Pages: 655-663

10.1080/13696998.2025.2496068 | PMID 40265856